VERACYTE, INC. — Director's Dealing 2020

Sep 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-08-31

Reporting Person: Hanna John Walter JR (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-31	Common Stock	M	53	$4	Acquired	74687	Direct
2020-08-31	Common Stock	M	9000	$14.34	Acquired	83687	Direct
2020-08-31	Common Stock	M	8835	$8.86	Acquired	92522	Direct
2020-08-31	Common Stock	M	19336	$6.45	Acquired	111858	Direct
2020-08-31	Common Stock	M	9375	$9.05	Acquired	121233	Direct
2020-08-31	Common Stock	M	9844	$5.98	Acquired	131077	Direct
2020-08-31	Common Stock	S	55970	$33.3674	Disposed	75107	Direct
2020-08-31	Common Stock	S	473	$33.7762	Disposed	74634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-31	Stock Option (right to buy)	$4	M	53	Disposed	2023-02-04	Common Stock (53)	Direct
2020-08-31	Stock Option (right to buy)	$14.34	M	9000	Disposed	2024-02-18	Common Stock (9000)	Direct
2020-08-31	Stock Option (right to buy)	$8.86	M	8835	Disposed	2025-03-01	Common Stock (8835)	Direct
2020-08-31	Stock Option (right to buy)	$6.45	M	19336	Disposed	2026-02-28	Common Stock (19336)	Direct
2020-08-31	Stock Option (right to buy)	$9.05	M	9375	Disposed	2027-03-02	Common Stock (9375)	Direct
2020-08-31	Stock Option (right to buy)	$5.98	M	9844	Disposed	2028-03-01	Common Stock (9844)	Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020.

F2: Represents weighted average sales price. Sale prices for the transactions range from $32.72 to $33.71. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.

F3: Represents weighted average sales price. Sale prices for the transactions range from $33.77 to $33.81. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.

F4: The option is fully vested.

F5: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F6: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.